Sign In to Track Progress

Don't have an account? Register

Take the Online Course

Free to Use
Start learning and review materials anytime without having to register.

Sign In and Save Your Progress
Create an account, sign in, and track your progress as you work.

Free Continuing Education
Sign in and obtain free CME or CNE as you work through the modules.

Available Modules

  1. This module is for any clinician who may encounter persons with hepatitis C virus infection and would like to establish core competence in testing for hepatitis C, counseling patients on preventing hepatitis C transmission, and diagnosing acute hepatitis C infection.
  2. This module is intended for clinicians involved in long-term management of persons with chronic hepatitis C infection. Content includes initial evaluation, natural history, preventing liver damage, staging of liver fibrosis, evaluation of cirrhosis, surveillance for hepatocellular carcinoma, and recognition of extrahepatic manifestations.
  3. This module addresses the diagnosis and management of complications that may arise in patients with cirrhosis, including ascites, spontaneous bacterial peritonitis, varicies, hepatic encephalopathy, and referral for liver transplantation. 
  4. This module is for clinicians evaluating patients for hepatitis C treatment, including clinicians who will independently assess treatment candidacy and clinicians who will provide treatment candidacy with assistance from a hepatitis C expert. 
  5. Module 5 is for clinicians treating chronic hepatitis C infection. Material covered includes recommendations for treatment-naive and treatment-experienced HCV-infected patients based on guidance from the AASLD, IDSA, and IAS-USA.
  6. This module is designed for clinicians who provide management of special populations of persons infected with HCV and/or complex HCV-related special treatment issues. Material covered is at a more advanced level.  
    In Development - Module Coming Soon
  7. This module is designed for clinicians who would like to review special topics that are not addressed in the existing curriculum. Rapidly changing, or cutting edge topics will be featured in this module. 

Progress Tracker

Module 1
This module is for any clinician who may encounter persons with hepatitis C virus infection and would like to establish core competence in testing for hepatitis C, counseling patients on preventing hepatitis C transmission, and diagnosing acute hepatitis C infection.
Module 2
This module is intended for clinicians involved in long-term management of persons with chronic hepatitis C infection. Content includes initial evaluation, natural history, preventing liver damage, staging of liver fibrosis, evaluation of cirrhosis, surveillance for hepatocellular carcinoma, and recognition of extrahepatic manifestations.
Module 3
This module addresses the diagnosis and management of complications that may arise in patients with cirrhosis, including ascites, spontaneous bacterial peritonitis, varicies, hepatic encephalopathy, and referral for liver transplantation. 
Module 4
This module is for clinicians evaluating patients for hepatitis C treatment, including clinicians who will independently assess treatment candidacy and clinicians who will provide treatment candidacy with assistance from a hepatitis C expert. 
Module 5
Module 5 is for clinicians treating chronic hepatitis C infection. Material covered includes recommendations for treatment-naive and treatment-experienced HCV-infected patients based on guidance from the AASLD, IDSA, and IAS-USA.
Module 7
This module is designed for clinicians who would like to review special topics that are not addressed in the existing curriculum. Rapidly changing, or cutting edge topics will be featured in this module. 
Lesson 1 
Objectives:

  1. Describe the epidemiology of hepatitis C in the United States.
  2. Understand the impact of the hepatitis C epidemic in the United States.

 
Objectives:

1. Summarize key aspects of the medical history and physical examination in persons with hepatiits C presenting for  an initial evaluation.  
2. List key immunizations that should be administered to persons with chronic hepatitis C infection.

 
Objectives:

1. Establish an understanding of appropriate technique for performing abdominal paracentesis.
2. Summarize appropriate medical management and dietary recommendations for patients with ascites. 

 
Objectives:

1. Discuss the goals and rationale for hepatitis C therapy with patients considering treatment. 
2. Predict a patient's response to treatment for chronic hepatitis C infection based on specific host and viral factors.

 
Objectives:

  1. Discuss preferred therapies for initial treatment and retreatment (of prior relapsers) who have genotype 1 chronic HCV.
  2. List the preferred therapy for retreatment of patients with HCV genotype 1 chronic infection who have failed therapy with a prior nonresponse (partial response or null response).

 
Objectives:

1. Discuss the rapidly changing treatment landscape for hepatic C. 
2. List 3 medications not yet FDA-approved that show promise for treating genotype 1 HCV. 

Lesson 2 
Objectives:

  1. Summarize CDC screening and testing recommendations for chronic hepatitis C infection.
  2. Discuss the impact of the 1945 to 1965 birth cohort hepatitis testing on the hepatitis C epidemic.

 
Objectives:

1. Describe the variable outcomes of that can occur in persons with chronic hepatitis C infection.
2. Discuss factors that influence the rate of progression of fibrosis in persons with chronic hepatitis C infection.

 
Objectives:

1. Differentiate spontaneous bacterial peritonitis from secondary bacterial peritonitis.
2. Select and utilize appropriate antimicrobial therapy for patients with spontaneous bacterial peritonitis.

 
Objectives:

1. Reflect on the indications, contraindications, and patient readiness when considering initiating hepatitis C therapy.
2. Integrate knowledge of new and future medications when considering the timing of initiating hepatitis C therapy.  

 
Objectives:

  1. List preferred therapies for initial treatment and retreatment with prior relapse for patients with genotype 2 chronic HCV.
  2. Describe the preferred therapy for retreatment of patients with HCV genotype 2 chronic infection who have failed therapy with a prior nonresponse (partial response or null response).

Lesson 3 
Objectives:

1. Describe screening and supplemental tests use for diagnosing hepatitis C infection. 
2. Discuss post-test counseling messages and linkage to care for  persons with active hepatitis C virus infection. 

 
Objectives:

1. Determine which common liver health counseling messages should be addressed in persons with chronic hepatitis C infection. 
2. Summarize key counseling messages related to over-the-counter medications, alcohol, marijuana, diet, and complementary medications in persons with chronic hepatitis C infection. 

 
Objectives:

  1. Indentify which patients with cirrrhosis should receive primary prophylaxis against variceal bleeding. 
  2. Use nonselective beta-blockers as prophylaxis against variceal bleeding when prophylaxis is indicated.

 
Objectives:

1. Design a system that utilizes one or more screening instruments for depression in patients considering hepatitis C therapy. 
2. Create a plan to provide appropriate support for patients with depression, bipolar disorder, or schizophrenia during hepatitis C therapy.

 
Objectives:

  1. List preferred therapies for treatment-naive patients with genotype 3 chronic HCV.
  2. State the preferred therapy for retreatment of patients with HCV genotype 3 chronic infection who have failed therapy with a prior nonresponse (partial response or null response).

Lesson 4 
Objectives:

  1. Summarize common routes of hepatitis C transmission.
  2. Discuss appropriate counseling to prevention the transmission of hepatitis C virus. 

 
Objectives:

1. Explain the indications, risks, and histologic assessment for liver biopsy in persons with chronic hepatitis C infection.
2. Examine non-invasive tests of liver fibrosis and examine the potential clinical utility of these tests. 

 
Objectives:

1. Summarize the clinical features of patients with hepatic encephalopathy and describe specific diagnostic tests. 
2. Utilize appropriate medical therapy for patients with hepatitic encephalopathy.

 
Objectives:

1. Summarize the impact of substance or alcohol abuse on hepatitis C treatment decisions.  
2. Integrate support services and management strategies into programs for patients with substance or alcohol abuse who need treatment for hepatitis C infection. 

 
Objectives:

  1. Understand the preferred therapies for treatment-naive patients with genotype 4 chronic HCV.
  2. State the preferred therapy for retreatment of patients with HCV genotype 4 chronic infection who have failed therapy with a prior nonresponse (partial response or null response).

Lesson 5 
Objectives:

1. Understand the clinical features, if present, in patients with acute hepatitis C infection. 
2. List appropriate tests to order for the laboratory diagnosis of acute hepatitis C infection.

 
Objectives:

1. Differentiate compensated cirrhosis from decompensated cirrhosis. 
2. Summarize classification and prognostic systems for patients with cirrhosis. 

 
Objectives:

1. Summarize the major indications and important timing events for liver transplantation evaluation referral. 
2. Determine a MELD score for all patients with cirrhosis and reflect on whether the score indicates a need for liver transplantaion referral. 

 
Objectives:

1. List different methods to measure patient adherence when receiving hepatitis C therapy. 
2. Identify barriers to adherence and discuss strategies than can maximize aherence. 

 
Objectives:

  1. List the preferred therapies for treatment-naive patients with genotype 5 or 6 chronic HCV.
  2. Discuss the preferred approach to retreatment of patients with HCV genotype 5 or 6 chronic infection who have failed therapy with a prior nonresponse (partial response or null response).

Lesson 6 
Objectives:

1. Determine which patients with chronic hepatitis C infection should undergo hepatocellular carcinoma surveillance. 
2. Describe the American Association for the Study of Liver Diseases (AASLD) recommendations for surveilance for hepatocellular carcinoma.

Lesson 7 
Self Assessment 
 
 
 
 

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.